Clinical Trial Update: Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 breast cancer trial comparing docetaxel followed by CEF versus docetaxel with capecitabine followed by CEX as adjuvant therapy; the study has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)
• Epirubicin (epirubicin)

Snippet

Sponsor: Finnish Breast Cancer Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED